Autopsy report · NCT03404089

Bedside Therapeutic Monitoring of β-Lactam Levels in Newborns, Children and Adolescents Admitted to Intensive Care.

“insufficient inclusions”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 2 months before it stopped.
• 13 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University Hospital, Lille

Sponsor type

University, hospital or other

Conditions

Intensive Care Unit Syndrome

Interventions

pharmacokinetic device; pharmacokinetic device

Participants

13

Sites

1

Countries

France

Trials that died the same way

• Pronostic Value of Endothelial Dysfunction in Heart Failure
  “Not enough inclusions” (92% match in meaning)
• Transfusion Effects in Myelodysplastic Patients: Limiting Exposure
  “Too few inclusions” (88% match in meaning)
• Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis
  “inclusion number not sufficient” (85% match in meaning)
• Development of a Predictive Score for Local Complications of Femoral Bifurcation Surgery
  “lack of inclusions” (83% match in meaning)
• Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study
  “Lack of inclusion” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.